Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Merck and Schering-Plough to Complete Merger
Merck & Co., 11/04/09
Under the terms of the agreement, Schering–Plough shareholders will receive 0.5767 shares of the newly combined company and $10.50 in cash for each share of Schering–Plough. Each Merck common share will automatically become a common share of the newly combined company.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Harris Corp. Buys VA Contractor
HealthDataManagement, 11/23/09
Article Search
Sponsor